Wolverine Trading, LLC Relmada Therapeutics, Inc. Call Options Transaction History

Wolverine Trading, LLC

  • $93.9 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$2.3 - $4.36 $19,780 - $37,496
8,600 Added 68.8%
21,100 $68,000
Q2 2024

Aug 14, 2024
SELL
$2.93 - $4.94 $17,580 - $29,640
-6,000 Reduced 32.43%
12,500 $37,000
Q1 2024

May 15, 2024
BUY
$3.1 - $6.8 $3,720 - $8,160
1,200 Added 6.94%
18,500 $86,000
Q4 2023

Feb 14, 2024
BUY
$2.45 - $4.22 $42,385 - $73,006
17,300 New
17,300 $71,000
Q4 2022

Feb 14, 2023
BUY
$2.17 - $35.84 $26,474 - $437,248
12,200 New
12,200 $43,000

Others Institutions Holding RLMD

# of Institutions
81
Shares Held
12.3M
Call Options Held
229K
Put Options Held
138K
View Full List

About RELMADA THERAPEUTICS, INC.

RLMD Quotes by TradingView
  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $10.9M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email